Luteolin Activates ERK1/2- and Ca-dependent HO-1 Induction That Reduces LPS-induced HMGB1, INOS/NO, and COX-2 Expression in RAW264.7 Cells and Mitigates Acute Lung Injury of Endotoxin Mice
Overview
Pathology
Affiliations
Objective: Although luteolin has shown to have anti-inflammatory action, no report is available whether luteolin inhibits HMGB1 and protects acute lung injury (ALI) in endotoxin rodents. We hypothesized that HO-1 induction by luteolin might play a crucial role for inhibition of pro-inflammatory mediators including HMGB1 through MAPK signaling in LPS-induced RAW264.7 cells, and it ameliorates ALI of endotoxin mice.
Methods: The effects of luteolin on the production of pro-inflammatory mediators in LPS-activated RAW264.7 cells and LPS-injected mice were evaluated. The mechanisms were investigated using various signal inhibitors.
Results: Luteolin significantly increased HO-1 expression through ERK1/2 signaling in a time- and concentration-dependent manner. Indeed, luteolin inhibited pro-inflammatory mediators (HMGB1, iNOS/NO, COX-2, and NF-κB activity) in LPS-activated RAW264.7 cells. In addition, PD98059, an ERK1/2 inhibitor, treatment failed to inhibit production of these pro-inflammatory mediators by luteolin. Interestingly, luteolin augmented HO-1 induction through Ca influx in RAW264.7 cells. Administration of luteolin significantly inhibited plasma HMGB1 level, and iNOS expression in the lung that resulted in a significant reduction of ALI in endotoxin mice that was reversed by a HO-1 inhibitor, ZnPPIX.
Conclusion: Therefore, we conclude that luteolin has a great potential for treatment of ALI and related diseases, where HMGB1 is a therapeutic target.
Natural Compounds Regulate Macrophage Polarization and Alleviate Inflammation Against ALI/ARDS.
Yin Z, Song R, Yu T, Fu Y, Ding Y, Nie H Biomolecules. 2025; 15(2).
PMID: 40001495 PMC: 11853067. DOI: 10.3390/biom15020192.
Cinnamaldehyde Alleviates Alveolar Epithelial Cell Injury in ALI by Inhibiting the CaMKII Pathway.
Liu L, Zhang H, Chen S, Dian W, Zheng Z Cell Biochem Biophys. 2024; 83(1):1097-1104.
PMID: 39316262 DOI: 10.1007/s12013-024-01544-x.
Li Z, Liang S, Cui X, Shen C, Xu Z, Chen W Front Psychiatry. 2024; 15:1414242.
PMID: 39247617 PMC: 11378754. DOI: 10.3389/fpsyt.2024.1414242.
Hu Y, Liu X, Song Y, Zhang Y, Li W, Zhang L Food Sci Nutr. 2024; 12(8):5426-5441.
PMID: 39139945 PMC: 11317744. DOI: 10.1002/fsn3.4193.
Jia Q, Wen J, Yang Q, Liu S, Zhang J, Wang T J Inflamm (Lond). 2023; 20(1):44.
PMID: 38115057 PMC: 10729360. DOI: 10.1186/s12950-023-00372-9.